Minimum Order Quantity | 4 Box |
Packaging Type | Box |
Brand | Jabryus |
Shelf Life | 24 Months |
Prescription/Non Prescription | Prescription |
Manufacturer | Glenmark |
Foam | Tablet |
Abrocitinib is a medication used for the treatment of atopic dermatitis (eczema)123. It is a Janus kinase inhibitor and it was developed by Pfizer1. Abrocitinib is taken by mouth1. It selectively inhibits Janus kinase (JAK) 1, which is thought to modulate multiple cytokines involved in pathophysiology of atopic dermatitis, including interleukin IL-4, IL-13, IL-31, IL-22, and thymic stromal lymphopoietin (TSLP)